The dual PI3K/mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild-type colorectal cancer.
<h4>Purpose</h4>To examine the in vitro and in vivo efficacy of the dual PI3K/mTOR inhibitor NVP-BEZ235 in treatment of PIK3CA wild-type colorectal cancer (CRC).<h4>Experimental design</h4>PIK3CA mutant and wild-type human CRC cell lines were treated in vitro with NVP-BEZ235, and the resulting effec...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science (PLoS)
2011-01-01
|
| Reeks: | PLoS ONE |
| Online toegang: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0025132&type=printable |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
